Anticoagulant medicines - Clinical trials 

  • Clinical trials

Clinical trials for Anticoagulant medicines

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Anticoagulant medicines. For all clinical trials, go to clinical trials search

This list shows clinical trials for Anticoagulant medicines

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Anticoagulant medicines
Title Recruitment status Location
European Pharmacogenetics of Anticoagulant Therapy Recruiting United Kingdom
European Multinational Registry on Prevention of Thromboembolic Events in Atrial Fibrillation Recruiting United Kingdom
To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection Recruiting United Kingdom
Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism Recruiting United Kingdom
A phase III, randomised, multicenter, double-blind, parallel-group, active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for the secondary prevention of venous thromboembolism. RE-MEDY - RE-MEDY Not Recruiting United Kingdom
A phase III, randomised, multicenter, double-blind, parallel-group, active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate 150 mg bid compared to warfarin INR 2.0-3.0 for the secondary prevention of venous thromboembolism RE-MEDY Secondary VTE prevention - RE-MEDY Not Recruiting United Kingdom
A phase III, randomised, double blind, parallel-group study of the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for 6 month treatment of acute symptomatic venous thromboembolism, following initial treatment for at least 5 days with a parenteral anticoagulant approved for this indication. RE-COVER II - RE-COVER II Not Recruiting United Kingdom
Randomized Evaluation of Long term anticoagulant therapy (RE-LY) comparing the efficacy and safety of two blinded doses of dabigatran etexilate with open label warfarin for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: prospective, multi-centre, parallel-group, non-inferiority trial (RE-LY STUDY) - RE-LY Not Recruiting United Kingdom
A phase III, randomised, double blind, parallel-group study of the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for 6 month treatment of acute symptomatic venous thromboembolism, following initial treatment (5-10 days) with a parenteral anticoagulant approved for this indication. RE-COVER - RE-COVER Not Recruiting United Kingdom
A phase III, randomised, multicenter, double-blind, parallel-group, active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for the secondary prevention of venous thromboembolism. RE-MEDY - RE-MEDY Not Recruiting United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member